Cerebral palsy patients at higher risk of receiving opioid prescriptions

Opioids are commonly prescribed as an all-purpose pain killer for patients with the condition

5:00 AM

Author | Valerie Goodwin

prescription pad yellow blue
Jacob Dwyer, Justine Ross, Michigan Medicine

The opioid crisis is an ongoing problem in the United States and certain populations are more susceptible to opioid exposure than others.

One of these populations? Adults with cerebral palsy.

Opioids are one approach to manage pain, but often work better for specific types of issues. Patients with cerebral palsy commonly experience pain, its complex, as it can last for different lengths of time (chronic, short-term) and have unique and many locations of where the pain stems from. For adult patients with cerebral palsy, opioids may not be as helpful to manage these types of pains.

Yet, recent research from the University of Michigan suggests that patients with cerebral palsy are more likely to be exposed to opioids and a higher volume of opioid prescriptions for a longer period of time. These results did not come as a surprise to the researchers.

“There is little research on the mechanisms of pain as individuals with cerebral palsy age throughout their life,” said Daniel Whitney, Ph.D., the lead author of the study and assistant professor of physical medicine and rehabilitation at Michigan Medicine. “Opioids may be prescribed at a higher rate for this population, but if it is not very effective at managing their types of pain, the risk-benefit ratio of opioid therapy seems unfavorably lopsided.”

See also: Opioid prescriptions significantly higher for patients with lifelong disabilities

Not much is known about how opioids impact the overall health of patients with cerebral palsy specifically. While opioids may help to manage short-term pain, they can also introduce side effects, such as mental health and substance abuse disorders, balance issues, and physical health problems.

“Opioids target specific pain mechanisms that can help with some elements of chronic pain, but there is a possibility that different routes for treatment can help target this pain more safely in terms of the person’s overall health,” said Ed Hurvitz, M.D., a physical medicine and rehabilitation specialist at Michigan Medicine and contributor to the paper.

Cerebral palsy populations are already medically vulnerable meaning they may be more likely to experience the negative side effects of opioids. The researchers hope that these findings prompt further research to investigate more appropriate opioid therapy and alternative routes to pain care for patients with cerebral palsy.

Alternatively, other common ways to treat this pain can vary from over-the-counter pain killers to specific stretches and exercises to help the areas of the body impacted. The researchers stress its important for providers to talk with their patients  about which methods are effective for them.

See also: Cerebral Palsy doesn’t cause death in adults, so why is it still listed as an underlying cause?

“The complex pain that patients with cerebral palsy experience can be treated in a variety of ways that have less side effects than opioids and create less exposure to the drug,” said Mark Peterson, Ph.D., M.S., FACSM, associate professor of physical medicine and rehabilitation at Michigan Medicine. “If you are prescribed opioids for pain and don’t feel that it is the right choice for you, it’s important to speak up to your care provider and search for other options.”

Additional authors: Daniel G. Whitney, Mark D. Peterson, and Edward A. Hurvitz

Funding: This work was supported by the National Institutes of Health (R01AR076994) and The American Occupational Therapy Foundation Health Services Research Grant.

Paper cited: “Population- and individual-level trajectories of opioid prescription patterns among adults with cerebral palsy: a retrospective cohort study,” National Public Health Emergency Collection. DOI: 10.1007/s11096-023-01553-5


More Articles About: All Research Topics Community Health Pharmacy Hospitals & Centers Cerebral Palsy Neurological Disorders
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories man in pink shirt close up with hand on stomach
Health Lab
Potential culprit identified in lingering Crohn’s disease symptoms
A study from University of Michigan researchers may explain why some patients with Crohn’s disease continue to experience symptoms, even in the absence of inflammation.
surgical area of clinicians drawn out with blue background
Health Lab
New tools that leverage NIH’s ‘All of Us’ dataset could improve anesthesia and surgical care
In a report in JAMA Surgery, researchers propose two novel tools that leverage the All of Us dataset to look at acute health events such as surgery.
prescription pad drawn
Health Lab
Reducing dose of popular blood thinners may limit risk of future bleeding
For people taking the popular blood thinners rivaroxaban (brand name Xarelto) and apixaban (brand name Eliquis), after having a blood clot, a reduced dose may limit the future risk of bleeding as well as hospital visits, a Michigan Medicine-led study suggests.
friends talking outside older walking smiling
Health Lab
Older adults’ health may get a little help from their friends 
Close friendships include help with health-related advice or support for people over 50, but those with major mental or physical health issues have fewer close friends.
navy brain on off white background with artificial intelligence lines inside with yellow highlighted areas
Health Lab
People want to know if AI is used in their health care
A study published in JAMA Network Open finds most people want to be notified if AI is used in their health care.
PURPLE BLUE RED CELLS FLOATING
Health Lab
Using cellular therapy to treat cancer, and beyond
Here, Monalisa Ghosh, M.D., a hematologist-oncologist at the University of Michigan Health Rogel Cancer Center, answers questions about cellular therapy; how it's used and what exciting developments are soon to come.